Logo image of ELV

ELEVANCE HEALTH INC (ELV) Stock Fundamental Analysis

USA - NYSE:ELV - US0367521038 - Common Stock

342.35 USD
-3.93 (-1.13%)
Last: 10/24/2025, 7:00:00 PM
342 USD
-0.35 (-0.1%)
After Hours: 10/24/2025, 7:00:00 PM
Fundamental Rating

4

ELV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. ELV has a medium profitability rating, but doesn't score so well on its financial health evaluation. ELV has a correct valuation and a medium growth rate. ELV also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ELV had positive earnings in the past year.
ELV had a positive operating cash flow in the past year.
Each year in the past 5 years ELV has been profitable.
ELV had a positive operating cash flow in each of the past 5 years.
ELV Yearly Net Income VS EBIT VS OCF VS FCFELV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

The Return On Assets of ELV (4.51%) is better than 74.26% of its industry peers.
ELV has a Return On Equity of 12.59%. This is in the better half of the industry: ELV outperforms 77.23% of its industry peers.
ELV has a Return On Invested Capital (5.32%) which is in line with its industry peers.
ELV had an Average Return On Invested Capital over the past 3 years of 6.90%. This is below the industry average of 9.28%.
Industry RankSector Rank
ROA 4.51%
ROE 12.59%
ROIC 5.32%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ELV Yearly ROA, ROE, ROICELV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 2.84%, ELV is in the better half of the industry, outperforming 65.35% of the companies in the same industry.
ELV's Profit Margin has declined in the last couple of years.
ELV has a Operating Margin of 4.35%. This is comparable to the rest of the industry: ELV outperforms 58.42% of its industry peers.
ELV's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.35%
PM (TTM) 2.84%
GM N/A
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
ELV Yearly Profit, Operating, Gross MarginsELV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ELV is destroying value.
ELV has less shares outstanding than it did 1 year ago.
ELV has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, ELV has a worse debt to assets ratio.
ELV Yearly Shares OutstandingELV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
ELV Yearly Total Debt VS Total AssetsELV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

The Debt to FCF ratio of ELV is 8.63, which is on the high side as it means it would take ELV, 8.63 years of fcf income to pay off all of its debts.
ELV has a Debt to FCF ratio of 8.63. This is comparable to the rest of the industry: ELV outperforms 55.45% of its industry peers.
A Debt/Equity ratio of 0.71 indicates that ELV is somewhat dependend on debt financing.
ELV has a Debt to Equity ratio (0.71) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 8.63
Altman-Z N/A
ROIC/WACC0.68
WACC7.87%
ELV Yearly LT Debt VS Equity VS FCFELV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ELV Yearly Current Assets VS Current LiabilitesELV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. Growth

3.1 Past

ELV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.71%.
ELV shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.17% yearly.
The Revenue has grown by 11.96% in the past year. This is quite good.
The Revenue has been growing by 11.14% on average over the past years. This is quite good.
EPS 1Y (TTM)-11.71%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-27.96%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%12%

3.2 Future

Based on estimates for the next years, ELV will show a small growth in Earnings Per Share. The EPS will grow by 7.89% on average per year.
The Revenue is expected to grow by 8.96% on average over the next years. This is quite good.
EPS Next Y-8.41%
EPS Next 2Y-3.9%
EPS Next 3Y1.64%
EPS Next 5Y7.89%
Revenue Next Year12.47%
Revenue Next 2Y8.69%
Revenue Next 3Y7.74%
Revenue Next 5Y8.96%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ELV Yearly Revenue VS EstimatesELV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50B 100B 150B 200B 250B
ELV Yearly EPS VS EstimatesELV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20 40 60

6

4. Valuation

4.1 Price/Earnings Ratio

ELV is valuated reasonably with a Price/Earnings ratio of 11.16.
Compared to the rest of the industry, the Price/Earnings ratio of ELV indicates a rather cheap valuation: ELV is cheaper than 88.12% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.91. ELV is valued rather cheaply when compared to this.
ELV is valuated reasonably with a Price/Forward Earnings ratio of 11.24.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ELV indicates a rather cheap valuation: ELV is cheaper than 84.16% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ELV to the average of the S&P500 Index (22.92), we can say ELV is valued rather cheaply.
Industry RankSector Rank
PE 11.16
Fwd PE 11.24
ELV Price Earnings VS Forward Price EarningsELV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ELV indicates a somewhat cheap valuation: ELV is cheaper than 72.28% of the companies listed in the same industry.
64.36% of the companies in the same industry are more expensive than ELV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.72
EV/EBITDA 10.1
ELV Per share dataELV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600 800

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1
EPS Next 2Y-3.9%
EPS Next 3Y1.64%

7

5. Dividend

5.1 Amount

ELV has a Yearly Dividend Yield of 1.98%.
ELV's Dividend Yield is rather good when compared to the industry average which is at 2.45. ELV pays more dividend than 90.10% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, ELV has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.98%

5.2 History

On average, the dividend of ELV grows each year by 15.34%, which is quite nice.
ELV has been paying a dividend for at least 10 years, so it has a reliable track record.
ELV has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)15.34%
Div Incr Years13
Div Non Decr Years13
ELV Yearly Dividends per shareELV Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

ELV pays out 27.56% of its income as dividend. This is a sustainable payout ratio.
The dividend of ELV is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP27.56%
EPS Next 2Y-3.9%
EPS Next 3Y1.64%
ELV Yearly Income VS Free CF VS DividendELV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
ELV Dividend Payout.ELV Dividend Payout, showing the Payout Ratio.ELV Dividend Payout.PayoutRetained Earnings

ELEVANCE HEALTH INC

NYSE:ELV (10/24/2025, 7:00:00 PM)

After market: 342 -0.35 (-0.1%)

342.35

-3.93 (-1.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-21 2025-10-21/bmo
Earnings (Next)01-21 2026-01-21/amc
Inst Owners93.05%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner Change2.2%
Market Cap77.09B
Revenue(TTM)194.82B
Net Income(TTM)5.53B
Analysts76.43
Price Target373.55 (9.11%)
Short Float %1.64%
Short Ratio1.59
Dividend
Industry RankSector Rank
Dividend Yield 1.98%
Yearly Dividend6.55
Dividend Growth(5Y)15.34%
DP27.56%
Div Incr Years13
Div Non Decr Years13
Ex-Date09-10 2025-09-10 (1.71)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.38%
Min EPS beat(2)-2.26%
Max EPS beat(2)21.02%
EPS beat(4)3
Avg EPS beat(4)5.76%
Min EPS beat(4)-2.26%
Max EPS beat(4)21.02%
EPS beat(8)5
Avg EPS beat(8)0.95%
EPS beat(12)8
Avg EPS beat(12)1.31%
EPS beat(16)11
Avg EPS beat(16)1.68%
Revenue beat(2)2
Avg Revenue beat(2)0.95%
Min Revenue beat(2)0.45%
Max Revenue beat(2)1.45%
Revenue beat(4)3
Avg Revenue beat(4)1.37%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)4.3%
Revenue beat(8)4
Avg Revenue beat(8)0.64%
Revenue beat(12)6
Avg Revenue beat(12)0.78%
Revenue beat(16)9
Avg Revenue beat(16)0.69%
PT rev (1m)0%
PT rev (3m)-22.07%
EPS NQ rev (1m)0.17%
EPS NQ rev (3m)-42.5%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)-13.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.16%
Valuation
Industry RankSector Rank
PE 11.16
Fwd PE 11.24
P/S 0.4
P/FCF 20.72
P/OCF 15.84
P/B 1.75
P/tB 18.46
EV/EBITDA 10.1
EPS(TTM)30.68
EY8.96%
EPS(NY)30.45
Fwd EY8.89%
FCF(TTM)16.52
FCFY4.83%
OCF(TTM)21.61
OCFY6.31%
SpS865.17
BVpS195.19
TBVpS18.54
PEG (NY)N/A
PEG (5Y)1
Graham Number367.07
Profitability
Industry RankSector Rank
ROA 4.51%
ROE 12.59%
ROCE 6.96%
ROIC 5.32%
ROICexc 5.73%
ROICexgc 9.91%
OM 4.35%
PM (TTM) 2.84%
GM N/A
FCFM 1.91%
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexgc growth 3Y-5.49%
ROICexgc growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.59
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 8.63
Debt/EBITDA 3.13
Cap/Depr 74.45%
Cap/Sales 0.59%
Interest Coverage 250
Cash Conversion 48.59%
Profit Quality 67.25%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC7.87%
ROIC/WACC0.68
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-11.71%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-27.96%
EPS Next Y-8.41%
EPS Next 2Y-3.9%
EPS Next 3Y1.64%
EPS Next 5Y7.89%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%12%
Revenue Next Year12.47%
Revenue Next 2Y8.69%
Revenue Next 3Y7.74%
Revenue Next 5Y8.96%
EBIT growth 1Y-10.69%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year-1.57%
EBIT Next 3Y2.35%
EBIT Next 5Y8.53%
FCF growth 1Y-54.88%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-48.85%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%

ELEVANCE HEALTH INC / ELV FAQ

Can you provide the ChartMill fundamental rating for ELEVANCE HEALTH INC?

ChartMill assigns a fundamental rating of 4 / 10 to ELV.


What is the valuation status for ELV stock?

ChartMill assigns a valuation rating of 6 / 10 to ELEVANCE HEALTH INC (ELV). This can be considered as Fairly Valued.


What is the profitability of ELV stock?

ELEVANCE HEALTH INC (ELV) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for ELV stock?

The Earnings per Share (EPS) of ELEVANCE HEALTH INC (ELV) is expected to decline by -8.41% in the next year.


Is the dividend of ELEVANCE HEALTH INC sustainable?

The dividend rating of ELEVANCE HEALTH INC (ELV) is 7 / 10 and the dividend payout ratio is 27.56%.